Ensuring access to medicines how to stimulate innovation to meet patients' needs?
In this respect, the creation of an entity to monitor clinical need, in conjunction with inequalities in access to essential medicines, merits consideration.7. Improving the efficiency of evidence generation in clinical research is not only good for driving down the costs of clinical trials, it can...
| Main Authors: | , |
|---|---|
| Corporate Authors: | , |
| Other Authors: | , |
| Format: | eBook |
| Language: | English |
| Published: |
Copenhagen, Denmark
World Health Organization, Regional Office for Europe
2018, [2018]
|
| Series: | Policy brief
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references